Sterling Investment Advisors, Ltd. Abb Vie Inc. Transaction History

Sterling Investment Advisors, Ltd.

$388 Million
Q4 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	SELL	$144.61 - $166.54 $20,679 - $23,815	-143 Reduced 0.84%	16,894 $2.69 Million
Q4 2022 Feb 06, 2023	SELL	$138.31 - $165.87 $5,947 - $7,132	-43 Reduced 0.25%	17,037 $2.76 Million
Q3 2022 Nov 03, 2022	SELL	$134.21 - $153.93 $7,247 - $8,312	-54 Reduced 0.32%	17,080 $2.29 Million
Q2 2022 Aug 05, 2022	BUY	$137.62 - $174.96 $83,397 - $106,025	606 Added 3.67%	17,134 $2.62 Million
Q1 2022 May 03, 2022	BUY	$131.98 - $163.75 $131 - $163	1 Added 0.01%	16,528 $2.68 Million
Q4 2021 Feb 02, 2022	SELL	$107.43 - $135.93 $46,194 - $58,449	-430 Reduced 2.54%	16,527 $2.24 Million
Q3 2021 Nov 09, 2021	SELL	$106.4 - $120.78 $45,752 - $51,935	-430 Reduced 2.47%	16,957 $1.83 Million
Q2 2021 Jul 29, 2021	BUY	$105.21 - $117.21 $841 - $937	8 Added 0.05%	17,387 $1.96 Million
Q1 2021 May 04, 2021	BUY	$102.3 - $112.62 $818 - $900	8 Added 0.05%	17,379 $1.88 Million
Q4 2020 Jan 21, 2021	BUY	$80.49 - $108.67 $34,852 - $47,054	433 Added 2.56%	17,371 $1.86 Million
Q3 2020 Oct 26, 2020	SELL	$85.91 - $100.83 $55,240 - $64,833	-643 Reduced 3.66%	16,938 $1.48 Million
Q2 2020 Jul 24, 2020	BUY	$73.37 - $98.18 $200,740 - $268,620	2,736 Added 18.43%	17,581 $1.73 Million
Q1 2020 Apr 30, 2020	BUY	$64.5 - $97.79 $32,701 - $49,579	507 Added 3.54%	14,845 $1.13 Million
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $21,278 - $26,623	-295 Reduced 2.02%	14,338 $1.27 Million
Q3 2019 Oct 15, 2019	SELL	$62.98 - $75.72 $93,903 - $112,898	-1,491 Reduced 9.25%	14,633 $1.11 Million
Q2 2019 Aug 06, 2019	SELL	$65.7 - $83.98 $3,482 - $4,450	-53 Reduced 0.33%	16,124 $1.17 Million
Q1 2019 May 01, 2019	SELL	$77.14 - $90.79 $65,029 - $76,535	-843 Reduced 4.95%	16,177 $1.3 Million
Q4 2018 Jan 18, 2019	SELL	$77.85 - $96.01 $17,360 - $21,410	-223 Reduced 1.29%	17,020 $1.57 Million
Q3 2018 Nov 09, 2018	SELL	$88.91 - $98.84 $1,778 - $1,976	-20 Reduced 0.12%	17,243 $1.63 Million
Q2 2018 Jul 26, 2018	BUY	$89.78 - $106.23 $77,480 - $91,676	863 Added 5.26%	17,263 $1.6 Million
Q1 2018 Apr 23, 2018	SELL	$92.01 - $123.21 $36,804 - $49,284	-400 Reduced 2.38%	16,400 $1.55 Million
Q3 2017 Nov 03, 2017	SELL	$69.85 - $89.22 $45,402 - $57,993	-650 Reduced 3.72%	16,800 $1.49 Million
Q2 2017 Aug 09, 2017	BUY	N/A	17,450	17,450 $1.27 Million

Others Institutions Holding ABBV

# of Institutions

3,943

Shares Held

1.26B

Call Options Held

16.8M

Put Options Held

12.1M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $337B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Investment Advisors, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sterling Investment Advisors, Ltd. with notifications on news.

Account